Brilliant Future AB Logo

Brilliant Future AB

A data-driven survey platform to measure and improve employee & customer experiences.

BRILL | ST

Overview

Corporate Details

ISIN(s):
SE0015811625 (+1 more)
LEI:
8945000UY9139ZSN0U50
Country:
Sweden
Address:
Drottninggatan 26, 111 51 Stockholm
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Brilliant Future AB is a data-driven survey and action platform specializing in employee experience (EX) and customer experience (CX). The company offers dedicated EX, CX, and Customer Service (CS) platforms that enable organizations to measure, analyze, and act on feedback from employees and customers. By transforming data into actionable insights, Brilliant Future helps clients make fact-based decisions, increase engagement, and drive business performance. With over 20 years of experience, the company serves clients in more than 50 countries, providing expert consulting support and benchmarks from 24 industries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Brilliant Future AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Brilliant Future AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway PCIB

Talk to a Data Expert

Have a question? We'll get back to you promptly.